Hadi Yaziji
- Oncology top 1%
- HER2/EGFR in Cancer Research 13
- Cancer Research top 2%
- Breast Cancer Treatment Studies 5
-
- Breast Lesions and Carcinomas 7
- Tumors and Oncological Cases 4
-
- Monoclonal and Polyclonal Antibodies Research 9
- Dermatology top 2%
- Cancer and Skin Lesions 4
-
- Glycosylation and Glycoproteins Research 5
- Renal and related cancers 3
- Co-authors
- Allen M. GownStuart J. SchnittRobert WerlingTimothy W. JacobsCarlos E. BacchiHarry C. HwangTodd BarryNeal S. Goldstein
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Hadi Yaziji
41 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 1.8k
- Cancer Research 680
- Pathology and Forensic Medicine 703
- Radiology, Nuclear Medicine and Imaging 878
- Dermatology 298
Countries citing papers authored by Hadi Yaziji
This map shows the geographic impact of Hadi Yaziji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadi Yaziji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadi Yaziji more than expected).
Fields of papers citing papers by Hadi Yaziji
This network shows the impact of papers produced by Hadi Yaziji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadi Yaziji. The network helps show where Hadi Yaziji may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hadi Yaziji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 2 | |
| 2 | 2008 | 85 | |
| 3 | 2007 | 176 | |
| 4 | 2006 | 132 | |
| 5 | 2006 | 61 | |
| 6 | Definitive diagnosis of pleural mesothelioma can be established on a small panel of immunohistochemical markers using logic regression, a novel statistical method | 2003 | 1 |
| 7 | 2002 | 18 | |
| 8 | 2002 | 141 | |
| 9 | False positive immunostaining of myofibroblasts and pericytes with antibodies to SMM-HC and calponin A pitfall in the interpretation of myoepithelial markers in breast lesions | 2001 | 1 |
| 10 | 2001 | 58 | |
| 11 | 2001 | 54 | |
| 12 | 2001 | 112 | |
| 13 | 2001 | 28 | |
| 14 | 2001 | 96 | |
| 15 | 2001 | 73 | |
| 16 | 2000 | 77 | |
| 17 | 1999 | 80 | |
| 18 | 1998 | 91 | |
| 19 | 1996 | 33 | |
| 20 | 1996 | 11 |
About Hadi Yaziji
Hadi Yaziji is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 42 papers that have together received 3.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Breast Lesions and Carcinomas (7 papers), Glycosylation and Glycoproteins Research (5 papers), Breast Cancer Treatment Studies (5 papers), Cancer and Skin Lesions (4 papers), Tumors and Oncological Cases (4 papers) and Renal and related cancers (3 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (680 citations) and Pathology and Forensic Medicine (703 citations). Hadi Yaziji has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Allen M. Gown, Stuart J. Schnitt, Robert Werling, Timothy W. Jacobs, Carlos E. Bacchi, Harry C. Hwang, Todd Barry, Neal S. Goldstein, Clive R. Taylor and Nour Sneige.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.